 IRVINE, Calif., Feb. 18, 2021 GLOBE NEWSWIRE -- ClearPoint Neuro, Inc. Nasdaq: CLPT the Company, a global therapy-enabling platform company providing navigation and delivery to the brain, announced today the pricing of its underwritten public offering of 1,850,140 shares of its common stock at a price to the public of 23.50 per share. In addition, the Company has granted the underwriters a 30-day option to purchase up to an additional 277,520 shares of its common stock at the public offering price less underwriting discounts and commissions. All the shares are being offered by the Company. The offering is expected to close on February 23, 2021, subject to customary closing conditions. 